[The industrialization of regenerative medicine--a potential market of $ 500 billion].
OBJECTIVE
To investigate the latest development of tissue engineered regenerative medicine in industrialization, with the intention to direct work in practical area.


METHODS
A complete insight of regenerative medicine in industrialization was obtained through referring to update publications, visiting related websites, as well as learning from practical experience.


RESULTS
The aerial view of the future of regenerative medicine was got based on knowledge of four different tissue engineering projects.


CONCLUSIONS
All present efforts should be devoted to regenerative medicine area meeting the industrialized trends.
Gu
Qisheng
Q
Shanghai Qisheng Institute of Biomaterial & Technology, Shanghai, 201106, PR China. qish@shqisheng.com
Zhang
Xueyan
X
Jiang
Lixia
L
D000818:Animals; D001672:Biocompatible Materials; D002454:Cell Differentiation; D049109:Cell Proliferation; D048271:Chitosan; D003920:Diabetes Mellitus / Q000628:therapy; D005337:Fibrin; D005346:Fibroblast Growth Factors / Q000627:therapeutic use; D006331:Heart Diseases / Q000628:therapy; D006801:Humans; D006820:Hyaluronic Acid; D051379:Mice; D044968:Regenerative Medicine / Q000191:economics*; D013124:Spinal Injuries / Q000628:therapy; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology; D023822:Tissue Engineering / Q000379:methods* / Q000639:trends
D001672:Biocompatible Materials; D005346:Fibroblast Growth Factors; D005337:Fibrin; D006820:Hyaluronic Acid; D048271:Chitosan